Venu Menon

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. pmc Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT])
    Venu Menon
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA
    Am J Cardiol 111:930-5. 2013
  2. ncbi request reprint Optimal management of acute aortic dissection
    Venu Menon
    Venu Menon, MD Division of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Treat Options Cardiovasc Med 11:146-55. 2009
  3. ncbi request reprint Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromes
    Venu Menon
    Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Med 119:584-90. 2006
  4. ncbi request reprint Incremental prognostic value of diastolic dysfunction in low risk patients undergoing echocardiography: beyond Framingham score
    Wael A AlJaroudi
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA
    Int J Cardiovasc Imaging 29:1441-50. 2013
  5. doi request reprint Outcomes of cardiac catheterization and percutaneous coronary intervention for in-hospital ventricular tachycardia or fibrillation cardiac arrest
    Thomas J Helton
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Catheter Cardiovasc Interv 80:E9-14. 2012
  6. ncbi request reprint Outcomes of culprit versus multivessel PCI in patients with multivessel coronary artery disease presenting with ST-elevation myocardial infarction complicated by shock
    Matthew A Cavender
    Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Invasive Cardiol 25:218-24. 2013
  7. doi request reprint Options for managing severe aortic stenosis: a case-based review
    Olcay Aksoy
    Department of CardiovascularMedicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 80:243-52. 2013
  8. doi request reprint Transfer of patients with suspected acute aortic syndrome
    Bhuvnesh Aggarwal
    Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA
    Am J Cardiol 112:430-5. 2013
  9. doi request reprint Do bisphosphonates slow the progression of aortic stenosis?
    Olcay Aksoy
    Department of Cardiovascular Medicine, Cleveland Clinic, Ohio 44195, USA
    J Am Coll Cardiol 59:1452-9. 2012
  10. doi request reprint Predictors and incremental prognostic value of left ventricular mechanical dyssynchrony response during stress-gated positron emission tomography in patients with ischemic cardiomyopathy
    Wael Aljaroudi
    Section of Cardiovascular Imaging, Division of Cardiovascular Medicine, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue J1 5, Cleveland, OH 44195, USA
    J Nucl Cardiol 19:958-69. 2012

Detail Information

Publications42

  1. pmc Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT])
    Venu Menon
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA
    Am J Cardiol 111:930-5. 2013
    ..Consistent with the overall trial results, stable patients with NSTEMI and a totally occluded IRA did not benefit from randomization to percutaneous coronary intervention...
  2. ncbi request reprint Optimal management of acute aortic dissection
    Venu Menon
    Venu Menon, MD Division of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Treat Options Cardiovasc Med 11:146-55. 2009
    ....
  3. ncbi request reprint Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromes
    Venu Menon
    Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Med 119:584-90. 2006
    ..An analysis of reginal variation across the United States in the treatment and outcomes of patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS) has not been previously performed...
  4. ncbi request reprint Incremental prognostic value of diastolic dysfunction in low risk patients undergoing echocardiography: beyond Framingham score
    Wael A AlJaroudi
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA
    Int J Cardiovasc Imaging 29:1441-50. 2013
    ..6 [1.25; 5.55], p = 0.01). In low-risk adult outpatients undergoing echocardiography, DD was associated with 2-3 fold increase in risk of death and had incremental prognostic value beyond FRS...
  5. doi request reprint Outcomes of cardiac catheterization and percutaneous coronary intervention for in-hospital ventricular tachycardia or fibrillation cardiac arrest
    Thomas J Helton
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Catheter Cardiovasc Interv 80:E9-14. 2012
    ....
  6. ncbi request reprint Outcomes of culprit versus multivessel PCI in patients with multivessel coronary artery disease presenting with ST-elevation myocardial infarction complicated by shock
    Matthew A Cavender
    Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Invasive Cardiol 25:218-24. 2013
    ....
  7. doi request reprint Options for managing severe aortic stenosis: a case-based review
    Olcay Aksoy
    Department of CardiovascularMedicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 80:243-52. 2013
    ..In this article, we use clinical vignettes to illustrate the management of patients with severe aortic stenosis...
  8. doi request reprint Transfer of patients with suspected acute aortic syndrome
    Bhuvnesh Aggarwal
    Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA
    Am J Cardiol 112:430-5. 2013
    ....
  9. doi request reprint Do bisphosphonates slow the progression of aortic stenosis?
    Olcay Aksoy
    Department of Cardiovascular Medicine, Cleveland Clinic, Ohio 44195, USA
    J Am Coll Cardiol 59:1452-9. 2012
    ..The aim of this study was to investigate the impact of bisphosphonates on the progression of aortic stenosis...
  10. doi request reprint Predictors and incremental prognostic value of left ventricular mechanical dyssynchrony response during stress-gated positron emission tomography in patients with ischemic cardiomyopathy
    Wael Aljaroudi
    Section of Cardiovascular Imaging, Division of Cardiovascular Medicine, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue J1 5, Cleveland, OH 44195, USA
    J Nucl Cardiol 19:958-69. 2012
    ....
  11. doi request reprint Cardiogenic shock in the setting of severe aortic stenosis: role of intra-aortic balloon pump support
    Olcay Aksoy
    Department of Cardiovascu Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    Heart 97:838-43. 2011
    ..To investigate the haemodynamic effects of intra-aortic balloon pump (IABP) support in patients with severe aortic stenosis (AS) presenting in cardiogenic shock (CS)...
  12. doi request reprint Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis
    Shikhar Agarwal
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Ohio, USA
    Arch Intern Med 172:623-31; discussion 631-3. 2012
    ..We performed a meta-analysis of safety and efficacy outcomes in patients with AF treated with warfarin for stroke prevention in large contemporary randomized controlled trials (RCTs)...
  13. doi request reprint Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention
    Dharam J Kumbhani
    Department of Cardiovascular Medicine, Cleveland Clinic, Ohio, USA
    Am J Cardiol 109:1087-91. 2012
    ..007). In conclusion, although overall mortality rates are similar between men and women undergoing PCI for NSTE-ACS, women <60 years old with negative biomarkers have a higher mortality than their men peers...
  14. doi request reprint Dynamic outflow tract obstruction in congenitally corrected transposition of the great arteries
    Andrew O Zurick
    Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Desk J1 5, Cleveland, OH 44195, USA
    Int J Cardiovasc Imaging 26:617-9. 2010
    ..Ultimately, our patient was felt to be too high-risk for surgical correction and a course of medical therapy has been pursued...
  15. doi request reprint Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis
    Akin Cam
    Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    J Thorac Cardiovasc Surg 142:800-8. 2011
    ....
  16. doi request reprint Dual antiplatelet therapy in coronary artery disease: a case-based approach
    Chad Raymond
    Internal Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 76:663-70. 2009
    ..The guidelines are based on strong evidence from several large randomized clinical trials over the last 10 years. The authors present several cases to show how to put this evidence into day-to-day clinical practice...
  17. doi request reprint Magnitude and consequences of missing the acute infarct-related circumflex artery
    Amar Krishnaswamy
    Cleveland Clinic Division of Cardiovascular Medicine, OH 44195, USA
    Am Heart J 158:706-12. 2009
    ..Heightened awareness of this clinical scenario and the available methods to avoid missing this elusive diagnosis are imperative in our quest to further improve the outcomes of patients with acute myocardial infarction...
  18. ncbi request reprint Measuring and treating serum lipids in patients in a chest pain observation unit
    Michael J Gillespie
    Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina, and The Cleveland Clinic, OH, USA
    Am J Cardiol 99:1718-20. 2007
    ..In addition to their primary role, CPOUs should focus on primary prevention and reduction of long-term risk...
  19. pmc Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial
    Venu Menon
    Division of Cardiology, F 15, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH 4419, USA
    Eur Heart J 30:183-91. 2009
    ..We evaluated the potential for selective benefit with PCI over MED for patients enrolled early in OAT...
  20. ncbi request reprint Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock
    Shun Kohsaka
    Department of Cardiology, Texas Heart Institute at St Luke s Episcopal Hospital and Baylor College of Medicine, Houston, USA
    Arch Intern Med 165:1643-50. 2005
    ....
  21. ncbi request reprint Meta-analysis of the cardiovascular outcomes with dipeptidyl peptidase 4 inhibitors: validation of the current FDA mandate
    Shikhar Agarwal
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk J 3 5, Cleveland, OH, 44195, USA
    Am J Cardiovasc Drugs 14:191-207. 2014
    ..We aimed to perform an updated meta-analysis of randomized controlled trials (RCTs) to investigate the differences in cardiovascular death, myocardial infarction (MI), and stroke between DPPI and placebo/alternative agents...
  22. doi request reprint Ranolazine: clinical applications and therapeutic basis
    Nael Hawwa
    Internal Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Am J Cardiovasc Drugs 13:5-16. 2013
    ..In this article we present the experimental and clinical data that support its current therapeutic role, and provide insight into potential future clinical applications...
  23. doi request reprint Utility of a novel watch-based pulse detection system to detect pulselessness in human subjects
    John Rickard
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Heart Rhythm 8:1895-9. 2011
    ..The Wriskwatch is a novel, watch-based pulse detection device that detects the loss of a radial pulse via advanced pulse detection technology and immediately contacts emergency medical systems...
  24. ncbi request reprint Lack of benefit with percutaneous intervention for late persistent occlusion after myocardial infarction: summary of the occluded artery trial
    Stephen Gimple
    Department of Cardiovascular Medicine, Cleveland Clinic, Ohio, USA
    J Cardiovasc Nurs 23:30-3. 2008
    ..No significant interaction between treatment effect and prespecified subgroups was observed. This lack of clinical benefit supports optimal medical therapy alone for Occluded Artery Trial-eligible patients in current clinical practice...
  25. doi request reprint Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: initial clinical experience in 1263 patients
    Deborah H Kwon
    Cleveland Clinic Foundation, 9500 Euclid Ave J1 5, Cleveland, Ohio 44195, USA
    J Nucl Cardiol 17:853-7. 2010
    ..Furthermore, low-level treadmill testing in a large population with regadenoson has not previously been evaluated. We describe our experience in the first 6 months of routine inpatient and outpatient clinical use...
  26. ncbi request reprint Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes
    Monvadi B Srichai
    Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am Heart J 147:84-90. 2004
    ....
  27. ncbi request reprint Cardiogenic shock: have we really found the magic potion?
    Venu Menon
    Eur Heart J 24:1279-81. 2003
  28. ncbi request reprint Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry
    Rupert Fincke
    New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York, USA
    J Am Coll Cardiol 44:340-8. 2004
    ..We sought to analyze clinical, angiographic, and outcome correlates of hemodynamic parameters in cardiogenic shock...
  29. ncbi request reprint Images in cardiovascular medicine. Acute myocardial infarction in uncorrected tetralogy of fallot
    Eugene Shteerman
    Division of Cardiology, St Lukes Roosevelt Hospital Center, New York, NY 10025, USA
    Circulation 106:e13-4. 2002
  30. pmc Management of cardiogenic shock complicating acute myocardial infarction
    Venu Menon
    Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina, USA
    Heart 88:531-7. 2002
  31. ncbi request reprint The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb
    Michael S Lee
    St Luke s Roosevelt Hospital Center, Columbia University, NY 10025, USA
    J Thromb Thrombolysis 14:91-101. 2002
    ..A large trial of thrombolysis for acute myocardial infarction has reported an association between longer aPTTs and adverse outcomes...
  32. ncbi request reprint Establishing a new target range for unfractionated heparin for acute coronary syndromes
    Michael S Lee
    St Luke s Roosevelt Hospital Center, Division of Cardiology, College of Physicians and Surgeons, Columbia University, 1111 Amsterdam Avenue, New York City, NY 10025, USA
    J Thromb Thrombolysis 17:121-6. 2004
    ....
  33. ncbi request reprint Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    Venu Menon
    Division of Cardiology, University of North Carolina at Chapel Hill, 27599, USA
    Chest 126:549S-575S. 2004
    ....
  34. ncbi request reprint Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patterns
    James W Hoekstra
    Department of Emergency Medicine, Wake Forest University Health Sciences, Medical Center Boulevard, Winston Salem, NC 27157, USA
    Acad Emerg Med 12:431-8. 2005
    ....
  35. ncbi request reprint Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials
    Mauricio G Cohen
    Division of Cardiology, University of North Carolina at Chapel Hill, 130 Mason Farm Road, CB 7075, Bioinformatics Building Suite 4128, Chapel Hill, NC 27599, USA
    Am J Med 118:482-8. 2005
    ..To correlate pulmonary artery catheterization (PAC) use and 30-day outcomes and to characterize the use of pulmonary artery catheters among patients with acute coronary syndromes (ACS)...
  36. ncbi request reprint Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergen
    Vladimir Dzavik
    Interventional Cardiology Program, University Health Network, and University of Toronto, Toronto, Ontario, Canada
    Am Heart J 149:1128-34. 2005
    ..We sought to determine the reason for this finding by examining the baseline characteristics and outcomes of the 2 treatment groups by age...
  37. ncbi request reprint Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Shaun G Goodman
    St Michael s Hospital, Division of Cardiology, 30 Bond Street, Queen, Toronto, Ontario, Canada
    Chest 133:708S-775S. 2008
    ....
  38. pmc Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease
    Michael S Lee
    Division of Cardiology, University of California, Los Angeles Medical Center, Los Angeles, CA 90095 171715, USA
    Ann Thorac Surg 86:29-34. 2008
    ..The ideal revascularization strategy (bypass surgery versus percutaneous coronary intervention [PCI]) for patients with cardiogenic shock in the setting of left main coronary artery disease is unknown...
  39. ncbi request reprint Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early imp
    Mauricio G Cohen
    Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7075, USA
    Am Heart J 152:110-7. 2006
    ..Data regarding the management of non-ST-segment elevation acute coronary syndromes (NSTE ACS) in Hispanic patients, the largest and fastest-growing minority in the United States, are scarce...
  40. ncbi request reprint Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial
    C Michael Gibson
    TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital and the Department of Medicine, Harvard Medical School, Boston, MA, USA
    Am Heart J 152:668-75. 2006
    ..Early restoration of epicardial flow before primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) has been associated with improved clinical outcomes...
  41. ncbi request reprint Comparison of bare metal stents versus drug-eluting stents on clinical decision making in patients with previous percutaneous coronary intervention admitted for suspected acute coronary syndrome
    Jatin Joshi
    Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA
    Am J Cardiol 98:338-40. 2006
    ....